Supriya Lifescience Future Growth
Future criteria checks 4/6
Supriya Lifescience is forecast to grow earnings and revenue by 21.6% and 19.5% per annum respectively. EPS is expected to grow by 21.4% per annum. Return on equity is forecast to be 16.2% in 3 years.
Key information
21.6%
Earnings growth rate
21.4%
EPS growth rate
| Pharmaceuticals earnings growth | 17.6% |
| Revenue growth rate | 19.5% |
| Future return on equity | 16.2% |
| Analyst coverage | Low |
| Last updated | 14 Feb 2024 |
Recent future growth updates
Recent updates
Little Excitement Around Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings
May 10
Lacklustre Performance Is Driving Supriya Lifescience Limited's (NSE:SUPRIYA) Low P/E
Feb 09Supriya Lifescience's (NSE:SUPRIYA) Shareholders May Want To Dig Deeper Than Statutory Profit
May 28Market Cool On Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings Pushing Shares 27% Lower
May 07Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2026 | 8,376 | 1,846 | N/A | N/A | 1 |
| 3/31/2025 | 6,864 | 1,500 | N/A | N/A | 1 |
| 3/31/2024 | 5,617 | 1,148 | N/A | N/A | 1 |
| 12/31/2023 | 5,545 | 1,204 | N/A | N/A | N/A |
| 9/30/2023 | 5,195 | 1,001 | 72 | 1,322 | N/A |
| 6/30/2023 | 4,916 | 931 | N/A | N/A | N/A |
| 3/31/2023 | 4,609 | 899 | -423 | 662 | N/A |
| 12/31/2022 | 5,069 | 978 | N/A | N/A | N/A |
| 9/30/2022 | 5,188 | 1,280 | -191 | 226 | N/A |
| 6/30/2022 | 5,545 | 1,693 | N/A | N/A | N/A |
| 3/31/2022 | 5,300 | 1,518 | -111 | 488 | N/A |
| 12/31/2021 | 4,754 | 1,543 | N/A | N/A | N/A |
| 3/31/2021 | 3,912 | 1,236 | 276 | 759 | N/A |
| 3/31/2020 | 3,200 | 734 | 915 | 1,161 | N/A |
| 3/31/2019 | 2,818 | 394 | 417 | 487 | N/A |
| 3/31/2018 | 2,168 | 87 | 228 | 278 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SUPRIYA's forecast earnings growth (21.6% per year) is above the savings rate (6.7%).
Earnings vs Market: SUPRIYA's earnings (21.6% per year) are forecast to grow faster than the Indian market (16.9% per year).
High Growth Earnings: SUPRIYA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SUPRIYA's revenue (19.5% per year) is forecast to grow faster than the Indian market (9.6% per year).
High Growth Revenue: SUPRIYA's revenue (19.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SUPRIYA's Return on Equity is forecast to be low in 3 years time (16.2%).